BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20883705)

  • 1. The role of the DNA hypermethylating agent Budesonide in the decatenating activity of DNA topoisomerase II.
    Orta ML; Domínguez I; Pastor N; Cortés F; Mateos S
    Mutat Res; 2010 Dec; 694(1-2):45-52. PubMed ID: 20883705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA demethylating 5-azaC induces endoreduplication in cultured Chinese hamster cells.
    Mateos S; Domínguez I; Pastor N; Cantero G; Cortés F
    Mutat Res; 2005 Oct; 578(1-2):33-42. PubMed ID: 16202795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halogen substitution of DNA protects from poisoning of topoisomerase II that results in DNA double-strand breaks.
    Cantero G; Mateos S; Pastor N; Cortés F
    DNA Repair (Amst); 2006 Jun; 5(6):667-74. PubMed ID: 16406738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
    Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
    Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA demethylation protects from cleavable complex stabilization and DNA strand breakage induced by the topoisomerase type I inhibitor camptothecin.
    Orta ML; Mateos S; Cortés F
    Mutagenesis; 2009 May; 24(3):237-44. PubMed ID: 19201781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teniposide-resistant CEM cells, which express mutant DNA topoisomerase II alpha, when treated with non-complex-stabilizing inhibitors of the enzyme, display no cross-resistance and reveal aberrant functions of the mutant enzyme.
    Chen M; Beck WT
    Cancer Res; 1993 Dec; 53(24):5946-53. PubMed ID: 8261408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells.
    Anderson H; Roberge M
    Cell Growth Differ; 1996 Jan; 7(1):83-90. PubMed ID: 8788036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high rate of endoreduplication in the repair deficient CHO mutant EM9 parallels a reduced level of methylated deoxycytidine in DNA.
    Mateos S; Domínguez I; Cantero G; Pastor N; Campanella C; Cortés F
    Mutat Res; 2008 Sep; 644(1-2):24-30. PubMed ID: 18640132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced sensitivity to topoisomerase inhibitors in synchronous CHO cells pre-treated with 5-azacytidine.
    López-Baena M; Mateos S; Piñero J; Trinidad Ortiz ; Cortés F
    Mutat Res; 1998 Oct; 421(1):109-16. PubMed ID: 9748527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role of topoisomerase II in linking DNA replication to chromosome condensation.
    Cuvier O; Hirano T
    J Cell Biol; 2003 Mar; 160(5):645-55. PubMed ID: 12604590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II: untangling its contribution at the centromere.
    Porter AC; Farr CJ
    Chromosome Res; 2004; 12(6):569-83. PubMed ID: 15289664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of halogenated DNA from strand breakage and sister-chromatid exchange induced by the topoisomerase I inhibitor camptothecin.
    Orta ML; Mateos S; Cantero G; Wolff LJ; Cortés F
    Mutat Res; 2008 Jan; 637(1-2):40-8. PubMed ID: 17706727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals. Evidence for the essential contribution of the enzyme to chromosome segregation.
    Pastor N; Cantero G; Campanella C; Cortés F
    Mutat Res; 2005 Apr; 582(1-2):11-9. PubMed ID: 15781205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
    Sakaguchi A; Kikuchi A
    J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II can unlink replicating DNA by precatenane removal.
    Lucas I; Germe T; Chevrier-Miller M; Hyrien O
    EMBO J; 2001 Nov; 20(22):6509-19. PubMed ID: 11707421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Condensin-dependent rDNA decatenation introduces a temporal pattern to chromosome segregation.
    D'Ambrosio C; Kelly G; Shirahige K; Uhlmann F
    Curr Biol; 2008 Jul; 18(14):1084-9. PubMed ID: 18635352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells.
    Wang L; Roy SK; Eastmond DA
    Mutat Res; 2007 Mar; 616(1-2):70-82. PubMed ID: 17174356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of DNA topoisomerases in cultured CHO cells treated with the antitumour drug 5-azacytidine.
    Piñero J; López-Baena M; Ortiz T; Mateos S; Cortés F
    Cytobios; 1999; 97(385):103-15. PubMed ID: 10418121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase activities and levels in irradiated Chinese hamster AA8 cells and in its radiosensitive mutant EM9.
    Pastor N; Piñero J; Ortiz T; Mateos JC; De Miguel M; Cortés F
    Int J Radiat Biol; 1999 Aug; 75(8):1035-42. PubMed ID: 10465370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.
    Ferguson LR; Whiteside G; Holdaway KM; Baguley BC
    Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.